Connect with us

International

German regulators deny Tilray's press release

Published

em

A Press release published on September 6th by Tilray Brands, titled “Tilray Initiates Roundtable With German Regulators to Kick-Off Draft Legislation to Legalize Adult-Use Cannabis in Germany” has been denied by German regulators and lawmakers, MJBizDaily reported. What for Tilray would be a preparatory phase of discussion for the upcoming legislative phase of adult cannabis use legalization, for German regulators was, after all, a "one-time conversation".

According to a spokesperson of Burkhard Blienert (the drug commissioner at the Federal Ministry of Health), to MJBizDaily, “the content of the press release is not correct. We are not downplaying the meeting, because there is no cooperation and there will be none either with Tilray. On no level to be clear.”

The case refers to a release of Tilray Brands, which turned out to be denied in MJBizDaily news and by the spokespersons of the deputies allegedly involved, one of whom stated that she was not even present at the conversation.

Tilray said it had started a policy roundtable with regulators on legalizing cannabis for adult use in Germany. “German Drug Commissioner Burkhard Blienert presented the plan for the legalization of cannabis for adult use and repeated the German government's announcement that a first draft of the project would be presented in the coming months. With this event, Tilray reaffirms its leading role as a trusted partner for government regulators and contributes to Germany's legalization efforts.” However, German regulators deny Tilray's press release.

Government denies cooperation with companies

The statement also mentioned that Burkhard Blienert, drug commissioner of the Federal Ministry of Health, Kristine Lütke, member of the Bundestag and spokesperson for drug policy, Carlos Kasper, member of the Bundestag and the Finance Committee, and Martina Stamm were at the meeting. -Fibich, member of the Bundestag and the Health Committee.

However, and according to information published by MJBizDaily, who questioned the respective regulators about this meeting, this is not what happened. New statements by spokespersons for the meeting participants said that this was an isolated conversation, not being part of the preparatory phase of legalization, and the German government spokesman refuted that any plan had been presented. In the conversation, “only the schedule was outlined, which has already been published several times” by the German government.

Kristine Lütke's chief of staff said the deputy did not participate in the conversation.

“We would like to inform you that there has not been a roundtable with Tilray and the Federal Government Commissioner for Addiction and Drug Issues,” a spokesman for Burkhard Blienert told MJBizDaily. “The content of the press release is not correct. We are not downplaying the meeting, because there is no cooperation and there will be none either with Tilray. On no level to be clear.”

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

More posts

I am one of the directors of CannaReporter, which I founded together with Laura Ramos. I am from the unique Island of Madeira, where I currently reside. While I was in Lisbon at FCUL studying Physical Engineering, I became involved in the national hemp and cannabis scene and participated in several associations, some of which I am still a member of. I follow the global industry and especially legislative advances regarding the different uses of cannabis.

I can be contacted by email at joao.costa@cannareporter.eu

Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertise with us!


Watch the Documentary "Patients" by Laura Ramos

Documentary Patients Laura Ramos help us grow

Mais recentes

Interviews3 days ago

Anar Artur: “Industrial hemp needs fresh and innovative solutions”

At 37, Anar Artur is one of the most committed voices in the promotion of hemp in Mongolia. With a career spanning...

Opinion3 days ago

The right to health and access to medicinal cannabis in Portugal: an unfulfilled constitutional promise

On May 31, 2025, the Cannabis March took place in Lisbon, where people from all over...

Events4 days ago

Berlin heats up for Cannabis Week with Mary Jane, Business of Cannabis B2B Sessions and CB Club x EmpowHer Meetup

The German capital will become the epicentre of the European cannabis scene next week, with a series of events...

Science5 days ago

CBD and CBDV demonstrate potent antifungal activity in peer-reviewed study

A study published in the journal PLOS Neglected Tropical Diseases confirms that cannabidiol (CBD) and cannabidivarin (CBDV) have potent...

ADVERTISING5 days ago

Lighting the Way Forward: Why EMEA Growers Are Rethinking Retrofits

A new era of grow efficiency begins with smarter lighting decisions. As growers grow...

Science5 days ago

Systematic review addresses risks and benefits of medicinal cannabis in mental health

A systematic review entitled “The differential effects of medicinal cannabis on mental health” carried out by researchers from Erasmus University in...

Science6 days ago

Study reveals that Paracetamol can act through the endocannabinoid system

A study carried out by researchers from the University of Indiana, in the United States of America, and Leiden, in the...

Events1 weeks ago

European Drugs Report 2025 highlights rise in synthetic substances; agency director questions whether CBD could be considered a precursor

(updated on 6/6/2025 at 23:57 pm) The European Drugs Agency (EUDA) presented yesterday in Lisbon the 30th Drug Report...

National2 weeks ago

Portugal: Infarmed changes requirements for import and export of medicinal cannabis. Companies concerned about speed of processes

Infarmed – National Authority for Medicines and Health Products IP has published new requirements for issuing certificates...

International2 weeks ago

Czech Republic authorizes cultivation of three cannabis plants and therapeutic use of psilocybin

The Czech Republic's parliament approved on May 30 a comprehensive reform of the criminal code, which legalizes...